Ozempic Tablets: Oral Semaglutide (Rybelsus), Dosing, and How It Compares to Injections

Many patients ask if Ozempic comes as a tablet. The short answer needs a little detail. Ozempic comes only as a subcutaneous injection (an injection under the skin).

But the same active ingredient, semaglutide, also comes as a tablet. That tablet is sold under the brand name Rybelsus.

Key distinctions:

• Ozempic: injectable semaglutide. Doses are 0.25 mg, 0.5 mg, and 1 mg, given once weekly
• Rybelsus: oral semaglutide. Doses are 3 mg, 7 mg, and 14 mg, taken once daily
• Both are made by Novo Nordisk
• Both contain semaglutide as the active ingredient
• They are not interchangeable without a prescriber's supervision. The dosing schedules, the amount the body absorbs, and the titration steps all differ

Licensing in the UK:

• The MHRA approved Rybelsus for type 2 diabetes in April 2020
• NICE TA 868 recommends Rybelsus for type 2 diabetes when a GLP-1 receptor agonist is suitable and the patient prefers a tablet
• Rybelsus is not licensed for weight management. Only Wegovy (semaglutide 2.4 mg injection) holds that licence

Why a tablet version was developed:

Peptide drugs are usually injected because stomach acid and digestive enzymes break them down. Novo Nordisk built a new absorption technology to get past this barrier.

As a result, semaglutide became the first GLP-1 receptor agonist you can take by mouth.

Rybelsus combines semaglutide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). SNAC is an absorption enhancer. It helps the peptide pass through the stomach lining into the body.

SNAC mechanism of action:

• SNAC raises the pH right at the tablet's surface. This shields semaglutide from pepsin, a stomach enzyme that would otherwise break it down
• It helps semaglutide pass across the stomach lining. This happens passively and depends on concentration
• Most absorption happens in the stomach, not the small intestine. That is why you must take the tablet on an empty stomach
• The body breaks down SNAC and removes it. SNAC has no drug effect of its own

Bioavailability considerations:

Bioavailability means how much of a dose reaches the bloodstream.

• Oral semaglutide has a bioavailability of about 0.4 to 1%. The subcutaneous injection reaches about 89%
• This is why the oral doses (3 mg, 7 mg, 14 mg) are much higher in milligrams than the injectable doses (0.25 mg, 0.5 mg, 1 mg). The higher amount is needed to reach similar blood levels
• Oral absorption varies a lot. It differs between patients, and even in the same patient on different days. Food, the amount of water, and the timing all change how much is absorbed

Strict administration requirements:

• Take it on an empty stomach after an overnight fast (at least 6 hours without food)
• Swallow it whole with up to 120 mL (half a glass) of plain water only
• Wait at least 30 minutes before you eat, drink other liquids, or take other oral medicines
• Do not crush, chew, or split the tablet

If you do not follow these steps, the body absorbs much less of the medicine. This lowers how well it works.

Like Ozempic, Rybelsus follows a titration schedule. Slowly raising the dose helps reduce gut side effects. The steps differ from the injectable product.

Step 1: 3 mg once daily for 30 days

This is a starting dose only. It does not lower glucose in a way that matters clinically. Its job is to let your gut adjust.

Do not stay on this phase longer than 30 days, because the 3 mg dose gives no treatment benefit.

Step 2: 7 mg once daily (first maintenance dose)

After 30 days at 3 mg, move up to 7 mg daily. The PIONEER trials showed this dose lowers HbA1c by about 10 to 13 mmol/mol (1.0 to 1.3%).

Step 3: 14 mg once daily (maximum dose)

If you need more blood sugar control after at least 30 days on 7 mg, move up to 14 mg. This dose lowers HbA1c by about 13 to 16 mmol/mol (1.3 to 1.5%).

It also gives the most weight loss of the oral doses.

Comparison of approximate HbA1c reduction by product and dose:

• Rybelsus 7 mg daily: 10 to 13 mmol/mol
• Rybelsus 14 mg daily: 13 to 16 mmol/mol
• Ozempic 0.5 mg weekly: 12 mmol/mol
• Ozempic 1 mg weekly: 16 to 18 mmol/mol

The injectable 1 mg dose lowers HbA1c a little more than the highest oral 14 mg dose. This likely reflects the higher and steadier bioavailability of the injection.

• Do not take two 7 mg tablets in place of one 14 mg tablet. They are not absorbed the same way
• If you miss a dose, skip it. Take your next dose at the usual time the following day

The PIONEER programme tested oral semaglutide across 10 Phase 3 trials in different clinical settings.

PIONEER 1 (monotherapy, 26 weeks):

• Rybelsus 14 mg: HbA1c reduction of 13 mmol/mol (1.5%), weight loss of 3.7 kg
• Placebo: HbA1c reduction of 1 mmol/mol (0.1%), weight loss of 1.4 kg

PIONEER 2 (vs empagliflozin 25 mg, added to metformin, 52 weeks):

• Rybelsus 14 mg: HbA1c reduction of 13 mmol/mol (1.3%), weight loss of 3.8 kg
• Empagliflozin 25 mg: HbA1c reduction of 9 mmol/mol (0.9%), weight loss of 3.7 kg
• Rybelsus lowered HbA1c more, and weight loss was similar

PIONEER 4 (vs liraglutide 1.8 mg, added to metformin, 52 weeks):

• Rybelsus 14 mg: HbA1c reduction of 12 mmol/mol (1.2%), weight loss of 4.4 kg
• Liraglutide 1.8 mg: HbA1c reduction of 11 mmol/mol (1.1%), weight loss of 3.1 kg
• Rybelsus was non-inferior for HbA1c (just as good) and gave more weight loss

PIONEER 7 (flexible dosing in real-world-like setting, 52 weeks):

• This trial showed that adjusting the dose based on HbA1c response at clinic visits is practical and works well

Across the programme, oral semaglutide 14 mg worked about as well as many injectable GLP-1 agonists.

Injectable semaglutide 1 mg (Ozempic) still holds a small edge in head-to-head modelled comparisons, because the body absorbs more of it.

The choice between Ozempic (injection) and Rybelsus (tablet) comes down to how well each works, what the patient prefers, and a few practical points.

Reasons to prefer Rybelsus (oral):

• Fear of needles, or a strong dislike of injections. This is common and valid
• A preference for a daily tablet over a weekly injection
• Frequent travel, where storing injections and disposing of sharps is awkward
• A wish to avoid lumps under the skin or reactions at the injection site

Reasons to prefer Ozempic (injection):

• A greater and steadier HbA1c reduction at the highest dose (1 mg weekly vs 14 mg daily)
• More weight loss, which matters when weight management is a goal
• Once-weekly dosing, which suits patients who want fewer medication moments
• No fasting needed. You can inject Ozempic at any time, with or without meals
• More predictable absorption. With Rybelsus, food and water change how much is absorbed
• Patients on several morning medicines who cannot keep the 30-minute fasting window

Cost considerations:

NICE TA 868 found Rybelsus cost-effective at the maker's confidential price. NHS Drug Tariff prices vary, and local formulary choices may favour one option.

Your prescriber can advise on what is available locally.

Switching between formulations:

You can switch from Rybelsus to Ozempic, or the other way round, with your prescriber's guidance. No washout period is needed. When switching from Rybelsus 14 mg to Ozempic, starting at 0.

5 mg weekly is usually right.

Rybelsus supply in the UK has improved since launch, though it still varies by region.

NHS prescribing pathway:

• Rybelsus is available on NHS prescription for type 2 diabetes
• NICE TA 868 (published August 2023) recommends oral semaglutide when a GLP-1 receptor agonist is suitable and a tablet is preferred
• Local formularies (once run by Clinical Commissioning Groups, now by Integrated Care Boards) may set their own criteria or need prior authorisation
• Some areas may need a specialist to start treatment, though GPs usually continue the prescription

Supply status:

• Rybelsus supply has been steadier than Ozempic. Demand for the injection has been driven by off-label use for weight loss
• Novo Nordisk sends supply updates through the DHSC from time to time. Check the Specialist Pharmacy Service or your local pharmacy for current stock
• All three strengths (3 mg, 7 mg, 14 mg) must be in stock for safe titration. Do not start a patient on Rybelsus if the 7 mg or 14 mg tablets cannot be reliably sourced

Private prescribing:

• Rybelsus is available through private clinics and online prescribing services
• Private prescriptions usually cost from 50 to 120 pounds a month, depending on the dose and supplier
• Patients who get Rybelsus privately should still have regular diabetes reviews with their NHS GP or specialist

Both Ozempic and Rybelsus need a prescription. Neither is available over the counter in the UK. Be careful about buying semaglutide from unregulated online sources.

The MHRA has found counterfeit products.